These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11856644)

  • 1. The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro.
    Taranta A; Brama M; Teti A; De luca V; Scandurra R; Spera G; Agnusdei D; Termine JD; Migliaccio S
    Bone; 2002 Feb; 30(2):368-76. PubMed ID: 11856644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 17beta-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleukin-6, transforming growth factor-beta1 and insulin-like growth factor-1 in primary human osteoblast cultures.
    Méndez-Dávila C; García-Moreno C; Turbì C; de la Piedra C
    J Endocrinol Invest; 2004 Nov; 27(10):904-12. PubMed ID: 15762036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures.
    Ramalho AC; Couttet P; Baudoin C; Morieux C; Graulet AM; de Vernejoul MC; Cohen-Solal ME
    Eur Cytokine Netw; 2002; 13(1):39-45. PubMed ID: 11956019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.
    Michael H; Härkönen PL; Kangas L; Väänänen HK; Hentunen TA
    Br J Pharmacol; 2007 Jun; 151(3):384-95. PubMed ID: 17420779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An estrogen receptor basis for raloxifene action in bone.
    Bryant HU; Glasebrook AL; Yang NN; Sato M
    J Steroid Biochem Mol Biol; 1999; 69(1-6):37-44. PubMed ID: 10418979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct mechanisms of action of selective estrogen receptor modulators in breast and osteoblastic cells.
    Nuttall ME; Stroup GB; Fisher PW; Nadeau DP; Gowen M; Suva LJ
    Am J Physiol Cell Physiol; 2000 Nov; 279(5):C1550-7. PubMed ID: 11029302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
    Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
    J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of genistein, estradiol and raloxifene on rat osteoclasts in vitro.
    Sliwiński L; Folwarczna J; Janiec W; Grynkiewicz G; Kuzyk K
    Pharmacol Rep; 2005; 57(3):352-9. PubMed ID: 15985718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
    Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI
    Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.
    Posritong S; Hong JM; Eleniste PP; McIntyre PW; Wu JL; Himes ER; Patel V; Kacena MA; Bruzzaniti A
    Mol Cell Endocrinol; 2018 Oct; 474():35-47. PubMed ID: 29428397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activities of estrogen receptor alpha and beta in yeast properties of raloxifene.
    Jisa E; Dornstauder E; Ogawa S; Inoue S; Muramatsu M; Jungbauer A
    Biochem Pharmacol; 2001 Oct; 62(7):953-61. PubMed ID: 11543731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro.
    Qu Q; Härkönen PL; Mönkkönen J; Väänänen HK
    Bone; 1999 Aug; 25(2):211-5. PubMed ID: 10456387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene.
    Miki Y; Suzuki T; Nagasaki S; Hata S; Akahira J; Sasano H
    J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):281-9. PubMed ID: 19429434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of raloxifene and estrogen on interleukin-1beta and interleukin-1 receptor antagonist production using in vitro and ex vivo studies.
    Rogers A; Clowes JA; Pereda CA; Eastell R
    Bone; 2007 Jan; 40(1):105-10. PubMed ID: 16934544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17beta-estradiol downregulates beta3-integrin expression in differentiating and mature human osteoclasts.
    Saintier D; Burde MA; Rey JM; Maudelonde T; de Vernejoul MC; Cohen-Solal ME
    J Cell Physiol; 2004 Feb; 198(2):269-76. PubMed ID: 14603529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of estradiol, methyl-piperidino-pyrazole, raloxifene, and ICI 182 780 on gene expression in the murine uterus.
    Davis AM; Mao J; Naz B; Kohl JA; Rosenfeld CS
    J Mol Endocrinol; 2008 Oct; 41(4):205-17. PubMed ID: 18632874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene.
    Cheung J; Mak YT; Papaioannou S; Evans BA; Fogelman I; Hampson G
    J Endocrinol; 2003 Jun; 177(3):423-33. PubMed ID: 12773123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets.
    De Wilde A; Lieberherr M; Colin C; Pointillart A
    J Cell Physiol; 2004 Aug; 200(2):253-62. PubMed ID: 15174095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluid shear stress and raloxifene stimulates the proliferation of osteoblast through regulating the expresstion of β-catenin and estrogen receptor α].
    Tang WR; Liu Y; Li LH; Wu ZB; He Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):913-8. PubMed ID: 25571714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.